Who Paid My Doc
CS006 RheOx Pivotal
Research payments
$7,041,216
Through program year 2025, $7,041,216 in research payments was reported against CS006 RheOx Pivotal, across 344 payments, paid by Galvanize Therapeutics, Inc.
- Paid by
- Galvanize Therapeutics, Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $821,920 | 104 |
| 2024 | Research | $2,316,831 | 110 |
| 2023 | Research | $2,734,697 | 99 |
| 2022 | Research | $1,167,767 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gerard Criner Philadelphia, PA Named on 15 payments
- Frank Sciurba Pittsburgh, PA Named on 14 payments
- Adnan Majid Boston, MA Named on 12 payments
- Mario Castro Kansas City, KS Named on 12 payments
- Richard Sue Gilbert, AZ Named on 11 payments
- Fabien Maldonado Nashville, TN Named on 10 payments
- Patrick Whitten Peoria, IL Named on 10 payments
- Joseph Thachuthara-George Birmingham, AL Named on 10 payments
- Michal Senitko Jackson, MS Named on 9 payments
- David Dibardino Philadelphia, PA Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.